JORGE MARTINEZ: Open Payments
NPI 1992748883 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,152 in 197 payments from 39 companies in 2025. Trend: 2023 $3,054 · 2024 $4,143 · 2025 $4,152
Food & beverage: $4,073Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $876 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 23 | $328 |
| Amgen Inc. | 20 | $301 |
| Otsuka America Pharmaceutical, Inc. | 10 | $218 |
| Grifols USA, LLC | 9 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $170 |
| Novo Nordisk Inc | 8 | $167 |
| Teva Pharmaceuticals USA, Inc. | 6 | $162 |
| ABBVIE INC. | 9 | $139 |
| Lilly USA, LLC | 9 | $137 |
Products named: AIRSUPRA, JARDIANCE, REXULTI, Prolastin-C Liquid, CAPLYTA, OTEZLA, BREZTRI, LOKELMA.
Industry payments across CA — which companies pay providers there.
